Wong CM - Search Results

1

HDPR1, a novel inhibitor of the WNT/beta-catenin signaling, is frequently downregulated in hepatocellular carcinoma: involvement of methylation-mediated gene silencing.

Yau TO, Chan CY, Chan KL, Lee MF, Wong CM, Fan ST, Ng IO. Yau TO, et al. Among authors: wong cm. Oncogene. 2005 Feb 24;24(9):1607-14. doi: 10.1038/sj.onc.1208340. Oncogene. 2005. PMID: 15580286

2

Clinicopathological significance of loss of heterozygosity on chromosome 13q in hepatocellular carcinoma.

Wong CM, Lee JM, Lau TC, Fan ST, Ng IO. Wong CM, et al. Clin Cancer Res. 2002 Jul;8(7):2266-72. Clin Cancer Res. 2002. PMID: 12114430

3

Deleted in liver cancer (DLC) 2 encodes a RhoGAP protein with growth suppressor function and is underexpressed in hepatocellular carcinoma.

Ching YP, Wong CM, Chan SF, Leung TH, Ng DC, Jin DY, Ng IO. Ching YP, et al. Among authors: wong cm. J Biol Chem. 2003 Mar 21;278(12):10824-30. doi: 10.1074/jbc.M208310200. Epub 2003 Jan 16. J Biol Chem. 2003. PMID: 12531887 Free article.

4

Genetic and epigenetic alterations of DLC-1 gene in hepatocellular carcinoma.

Wong CM, Lee JM, Ching YP, Jin DY, Ng IO. Wong CM, et al. Cancer Res. 2003 Nov 15;63(22):7646-51. Cancer Res. 2003. PMID: 14633684

5

Evaluation of nuclear factor-kappaB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma.

Chan CF, Yau TO, Jin DY, Wong CM, Fan ST, Ng IO. Chan CF, et al. Among authors: wong cm. Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):4140-9. doi: 10.1158/1078-0432.CCR-03-0574. Clin Cancer Res. 2004. PMID: 15217951

6

The liver-enriched transcription factor CREB-H is a growth suppressor protein underexpressed in hepatocellular carcinoma.

Chin KT, Zhou HJ, Wong CM, Lee JM, Chan CP, Qiang BQ, Yuan JG, Ng IO, Jin DY. Chin KT, et al. Among authors: wong cm. Nucleic Acids Res. 2005 Mar 30;33(6):1859-73. doi: 10.1093/nar/gki332. Print 2005. Nucleic Acids Res. 2005. PMID: 15800215 Free PMC article.

7

Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma.

Wong CM, Yam JW, Ching YP, Yau TO, Leung TH, Jin DY, Ng IO. Wong CM, et al. Cancer Res. 2005 Oct 1;65(19):8861-8. doi: 10.1158/0008-5472.CAN-05-1318. Cancer Res. 2005. PMID: 16204057 Free article.

8

Deleted in liver cancer 2 (DLC2) suppresses cell transformation by means of inhibition of RhoA activity.

Leung TH, Ching YP, Yam JW, Wong CM, Yau TO, Jin DY, Ng IO. Leung TH, et al. Among authors: wong cm. Proc Natl Acad Sci U S A. 2005 Oct 18;102(42):15207-12. doi: 10.1073/pnas.0504501102. Epub 2005 Oct 10. Proc Natl Acad Sci U S A. 2005. PMID: 16217026 Free PMC article.

9

Tissue factor pathway inhibitor-2 as a frequently silenced tumor suppressor gene in hepatocellular carcinoma.

Wong CM, Ng YL, Lee JM, Wong CC, Cheung OF, Chan CY, Tung EK, Ching YP, Ng IO. Wong CM, et al. Among authors: wong cc. Hepatology. 2007 May;45(5):1129-38. doi: 10.1002/hep.21578. Hepatology. 2007. PMID: 17464989

10

Molecular pathogenesis of hepatocellular carcinoma.

Wong CM, Ng IO. Wong CM, et al. Liver Int. 2008 Feb;28(2):160-74. doi: 10.1111/j.1478-3231.2007.01637.x. Epub 2007 Dec 6. Liver Int. 2008. PMID: 18069974 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

573 results

Search Page

Filters